Table 2 Study characteristics (n = 41)
From: Predictors of health-related quality of life after cardiac surgery: a systematic review
Study (Author, year, country) | Study design (including (number of sites)) | Patients (population (type of surgery) and sample size) | HRQoL tool used and time-point of predictive model (months unless otherwise stated) | ||
|---|---|---|---|---|---|
Type of surgery | Sample size | ||||
Participation rate of eligible persons | Completed follow-up: total cohort | ||||
Myles 2001 [12] Australia | Pre-op post-op (1) | CABG, valve, combined, other | 120/125 (96%) | 108/120 (90%) | SF-36 (3) |
Baldassarre 2002 [15] Canada | Prospective cohort (1) | Isolated CABG (primary) | 34/64 (53%) | 30/34 (88%) | SF-36 (3) |
Falcoz 2003 [34] France | Prospective cohort (1) | CABG, valve, combined, other (elective) | 293/452 (65%) | 264/293 (90%) | SF-36 (12) |
Herlitz 2003 [57] Sweden | Prospective cohort (2) | Isolated CABG (primary) | 1225/2000 (61%) | 976/2000 (49%) | NHP (10 years) |
Schelling 2003 [58] Germany | Prospective cohort (1) | CABG, valve, combined | 223/387 (58%) | 148/223 (66%) | SF-36 (6) |
Baberg 2004 [17] Germany | Prospective and retrospective cohort (1) | AVR ± MVR | 201/414 (47%) | 201/414 (49%) | SF-36 (3 years)a |
Jarvinen 2004 [28] Finland | Prospective cohort (1) | Isolated CABG | 501/1128 (44%) | 458/501 (91%) | SF-36 (12) |
Rumsfeld 2004 [18] America | Prospective cohort (14) | Isolated CABG (primary) | 2480/3956 (63%) | 1973/2480 (80%) | SF-36 (6) |
Al-Ruzzeh 2005 [19] UK | Cross-sectional (1) | Isolated CABG (primary) | 437/463 (94%) | NA | SF-36 (12)a |
Herlitz 2005 [59] Sweden | Prospective cohort (1) | Isolated CABG (primary) | 1225/2000 (61%) | 637/1225 (52%) | NHP (10 years)b |
Peric 2005 [60] Serbia and Montenegro | Prospective cohort (1) | Elective CABG | 243 (no mention of consent/refusal rate) | 226/243 (93%) | NHP (6) |
Le Grande 2006 [20] Australia | Pre-op post-op (1) | Elective CABG | 182/407 (45%) | 117/182 (64%) | SF-36 (2, 6) |
Myles 2006 [4] Australia | Pre-op post-op (1) | CABG, valve, combined, other | 108/120 (90%) | 93/108 (86%) | SF-36 (3, 3 years) |
Noyez 2006 [61] Netherlands | Retrospective cohort (1) | Isolated CABG | 428/428 (100%) | 428/428 (100%) | EQ-5D (12) |
Panagopoulou2006 [62] Greece | Prospective cohort (1) | Elective CABG | 157/256 (61%) | 1mo:117/157 (75%) 6mo:104/157 (66%) | MNHD-Q (1, 6) |
Dunning 2008 [63] England | Prospective cohort (1) | Isolated CABG | 911/1180 (77%) | 621/911 (68%) | EQ-5D (10)a |
El Baz 2008 [32] Netherlands | Prospective observational (2) | CABG | 198/256 (73%) | 168/198 (85%) | SF-36 (6) |
Jokinen 2008 [48] Finland | Prospective observational cohort (1) | CABG, valve, combined, other | 91/98 (93%) | 46/91 (51%) | NHP (15, 8.2 years)b |
Peric 2008 [64] Serbia | Pre-op post-op (1) | Isolated CABG | Not reported | 192/208 (92%) | NHP (6) |
Deaton 2009 [31] USA | Prospective cohort (2) | Isolated CABG | 317/442 (72%) | 270/317 (85%) | SF-36 (3)a |
Herlitz 2009 [65] Sweden | Prospective cohort (2) | Isolated CABG (primary) | Not reported 2000 screened | 639/2000 (32%) | NHP (15 years) |
Maisano 2009 [66] Italy (implied by authorship, not stated) | Retrospective cohort with prospective assessment of HRQoL (1) (implied) | Mitral valve surgery (± AVR, ± TV surgery, ± CABG) | 225/225 (100%) | 220/225 (98%) | MLHF (3 years)a |
Rantanen 2009 [67] Finland | Prospective cohort (1) | Elective CABG | 1 mo:274/367 (75%) 6 mo:244/271 (90%) 12 mo:236/266 (89%) | 1 mo:270/274 (99%) 6 mo:240/244 (98%) 12 mo:235/236 (100%) | 15D (1, 6, 12) |
Juergens 2010 [30] Germany | Prospective cohort (1) | Elective CABG, valve, combined | 56/85 (65%) | 42/65 (75%) | SF-12 (3) |
Peric 2010 [68] Serbia | Prospective pre-op post-op (1) | Elective CABG | 243/243 (100%) | 226/243 (93%) | NHP (6) |
Grady 2011 [21] America | Prospective cohort (1) | CABG, valve, maze, combined | 840/2524 (33%) | 0 mo:173/840 (21%) 6 mo:177/840 (21%) 12 mo:174/840 (21%) 24 mo:129/840 (15%) 36 mo:69/840 (8%) Total:816/840 (97%) | SF-36 (3, 6, 12, 2 years, 3 years) |
Vainiola 2013 [47] Finland | Prospective cohort (1) | CABG, valve, combined, aortic, other | 785/980 (80%) | 571/785 (73%) | 15-D (6) |
Kurfirst 2014 [14] Czech republic | Prospective cohort (1) | CABG, valve, combined (elective) | 310 eligible | 260/310 (84%) | SF-36 (12) |
Humphreys 2016 [33] Australia | Prospective cohort (1) | Elective CABG | 180 agreed to participate. No further details | 173/180 (96%) | SF-36 (6) |
Patron 2016 [22] Italy | Pre-op post-op (1) | CABG, valve, combined (primary, elective) | 92/92 (100%) | 75/92 (82%) | SF-12 (12) |
Bjornnes 2017 [69] Norway | Secondary analysis of RCT (2) | CABG, valve, combined | 416/525 (79%) | 349/416 (84%) | 15D (2 weeks, 3,6,12) |
Norkiene 2018 [13] Lithuania | Prospective cohort (1) | CABG, valve, combined | 210/210 (100%) No further details | 105/210 (50%) | SF-36 (12) |
Bishawi 2018 [70] America | Secondary analysis of RCT (18) | Isolated CABG (urgent or elective) | 2203/3670 (60%) | 1770/2203 (80%) | SAQVR-36 (12) |
Grand 2018 [23] France | Prospective cohort (1) | CABG, valve, combined (elective) | 495/548 (90%) | 326/495 (66%) | SF-36 (6) |
Coelho 2019 [24] Portugal | Prospective cohort (1) (implied) | CABG, valve, combined (elective) | Not stated | 384/430 (89%) | SF-36 (12) |
Blokzijl 2019 [25] Netherlands | Retrospective cohort multicentre (3) | Elective CABG | 2606/8643 (30%) | 2606/8643 (30%) | SF-36 or SF12 (10–14) |
Joskowiak 2019 [26] Germany | Prospective cohort (1) | CABG, valve, combined, aortic, other, redo (elective) | 164 consented but does not state number who were eligible and screened | 164/164 (100%) | SF-36 (12) |
Perrotti 2019 [27] France | Prospective cohort (1) | Isolated CABG (elective) | 272/272 (100%) | 118/272 (43%) | SF-36 (10 years) |
Kube 2020 [35] Germany | Prospective cohort (2) | CABG, valve, combined (elective) | 70/110 (64%) | 53/70 (76%) | SF-12 (6) |
Rijnhart-de Jong 2020 [29] | Prospective cohort (1) | Non-salvage cardiac surgery | 1544/1773 (87%) | 874/1544 (57%) | SF-36 (12) |
Schaal 2020 [71] Germany | Prospective cohort (1) | CABG, valve, combined, aortic, | 8676/14043 (62%) | 8676/14043 (62%) | NHP (6) |